PLIVA

PLIVA is the largest pharmaceutical company in Croatia and a leading player in Central and Eastern Europe. Founded in 1921, the company gained global fame for the discovery of the blockbuster antibiotic Azithromycin (Sumamed). Today, PLIVA operates as a key strategic subsidiary of Teva Pharmaceutical Industries, serving as one of Teva's primary hubs for R&D and manufacturing in Europe. The company specializes in the development and production of finished dosage forms (FDF) and active pharmaceutical ingredients (API). Its Zagreb facility is one of the most advanced pharmaceutical manufacturing sites in the region, while its Savski Marof site is a major center for API production. PLIVA's portfolio includes a wide range of generic medicines, specialty pharmaceuticals, and over-the-counter (OTC) products across various therapeutic areas.